3-Monothiopomalidomide Reduces Alpha-Synuclein Aggregation and Neuroinflammation in Parkinson’s Models
In cellular assays and a rat model of Parkinson’s disease, the novel immunomodulator 3-monothiopomalidomide inhibited alpha-synuclein aggregation, reduced neuroinflammation, and ...





